Cargando…
Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity
We have shown that in the human peripheral blood cells, the innate immunity protein Tag7 can activate a subpopulation of CD3+CD4+CD25+ cells, which have antitumor activity. These cells can induce lysis of HLA-negative tumor cell lines. The Hsp70 stress molecule on the surface of the tumor cells is u...
Autores principales: | Sharapova, T. N., Romanova, E. A., Sashchenko, L. P., Yashin, D. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925135/ https://www.ncbi.nlm.nih.gov/pubmed/29850628 http://dx.doi.org/10.1155/2018/4501273 |
Ejemplares similares
-
N-Terminal Peptide of PGLYRP1/Tag7 Is a Novel Ligand for TREM-1 Receptor
por: Sharapova, Tatiana N., et al.
Publicado: (2022) -
Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface
por: Ivanova, O. K., et al.
Publicado: (2023) -
Short Peptides of Innate Immunity Protein Tag7 (PGLYRP1) Selectively Induce Inhibition or Activation of Tumor Cell Death via TNF Receptor
por: Yurkina, Daria M., et al.
Publicado: (2023) -
Cytokines TNFα, IFNγ and IL-2 Are Responsible for Signal Transmission from the Innate Immunity Protein Tag7 (PGLYRP1) to Cytotoxic Effector Lymphocytes
por: Sharapova, Tatiana N., et al.
Publicado: (2020) -
Mechanisms of Action of the PGLYRP1/Tag7 Protein in Innate and Acquired Immunity
por: Yashin, D. V., et al.
Publicado: (2021)